Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis

K. Brabnikova Maresova, K. Jarosova, K. Pavelka, JJ. Stepan,

. 2014 ; 15 (-) : 51.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008282

BACKGROUND: The study is aimed to evaluate body composition and bone status in adolescent and adult patients with active juvenile idiopathic arthritis (JIA) untreated with tumor necrosis factor alpha inhibitors. METHODS: Adult patients (12 male and 19 female) with active JIA and 84 healthy age- and gender- matched controls were enrolled into the study. Body composition (tissue mass in grams, lean mass, fat mass and bone mineral content as a fraction of tissue mass) and areal bone mineral density parameters (aBMD) at the lumbar spine, proximal femur, femoral neck, distal radius and total body were assessed using dual energy x-ray absorptiometry (DXA), and correlated with clinical characteristics of the disease and physical performance tests. Disease activity was assessed using high-sensitivity C-reactive protein (hsCRP) and disease activity score 28 (DAS 28). Differences between the groups were tested by t-test, and One-way ANOVA. Correlations were assessed using the Pearson correlation coefficients and multiple linear regression analysis. Significances were counted at the 0.05 level. RESULTS: In patients with clinically active JIA (DAS 28, 6.36 ± 0.64, hsCRP, 18.36 ± 16.95 mg/l), aBMD at all measured sites, bone mineral content (BMC) and lean mass were reduced, and fat mass was increased as compared with healthy controls. Significant negative correlations were observed between BMC and disease duration, use of glucocorticoids (GCs), and fat mass, respectively. A positive correlation was found between BMC and lean mass, and between the body fat fraction and the use of GCs. Using multiple linear regression analysis, lean mass was the only significant predictor of BMC of total body both in men and women, and of BMC of legs (only in men). Lean mass was also the only predicting factor of total proximal femur BMD and femoral neck BMD. No significant correlations have been determined among the body composition parameters and DAS 28 or hsCRP endpoints. CONCLUSIONS: In adult patients with long-term active JIA, lean mass was the main determining factor of total body and leg BMC, and total proximal femur and femoral neck aBMD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008282
003      
CZ-PrNML
005      
20150313101142.0
007      
ta
008      
150306s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/1471-2474-15-51 $2 doi
035    __
$a (PubMed)24558956
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Brabnikova Maresova, Kristyna $u Institute of Rheumatology, Na Slupi 4, 128 50 Prague, Czech Republic. maresova.kristyna@seznam.cz.
245    14
$a The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis / $c K. Brabnikova Maresova, K. Jarosova, K. Pavelka, JJ. Stepan,
520    9_
$a BACKGROUND: The study is aimed to evaluate body composition and bone status in adolescent and adult patients with active juvenile idiopathic arthritis (JIA) untreated with tumor necrosis factor alpha inhibitors. METHODS: Adult patients (12 male and 19 female) with active JIA and 84 healthy age- and gender- matched controls were enrolled into the study. Body composition (tissue mass in grams, lean mass, fat mass and bone mineral content as a fraction of tissue mass) and areal bone mineral density parameters (aBMD) at the lumbar spine, proximal femur, femoral neck, distal radius and total body were assessed using dual energy x-ray absorptiometry (DXA), and correlated with clinical characteristics of the disease and physical performance tests. Disease activity was assessed using high-sensitivity C-reactive protein (hsCRP) and disease activity score 28 (DAS 28). Differences between the groups were tested by t-test, and One-way ANOVA. Correlations were assessed using the Pearson correlation coefficients and multiple linear regression analysis. Significances were counted at the 0.05 level. RESULTS: In patients with clinically active JIA (DAS 28, 6.36 ± 0.64, hsCRP, 18.36 ± 16.95 mg/l), aBMD at all measured sites, bone mineral content (BMC) and lean mass were reduced, and fat mass was increased as compared with healthy controls. Significant negative correlations were observed between BMC and disease duration, use of glucocorticoids (GCs), and fat mass, respectively. A positive correlation was found between BMC and lean mass, and between the body fat fraction and the use of GCs. Using multiple linear regression analysis, lean mass was the only significant predictor of BMC of total body both in men and women, and of BMC of legs (only in men). Lean mass was also the only predicting factor of total proximal femur BMD and femoral neck BMD. No significant correlations have been determined among the body composition parameters and DAS 28 or hsCRP endpoints. CONCLUSIONS: In adult patients with long-term active JIA, lean mass was the main determining factor of total body and leg BMC, and total proximal femur and femoral neck aBMD.
650    _2
$a absorpční fotometrie $7 D015502
650    _2
$a adipozita $7 D050154
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a věk při počátku nemoci $7 D017668
650    _2
$a juvenilní artritida $x metabolismus $x patologie $7 D001171
650    12
$a složení těla $7 D001823
650    12
$a kostní denzita $7 D015519
650    _2
$a metabolické nemoci kostí $x etiologie $7 D001851
650    _2
$a C-reaktivní protein $x analýza $7 D002097
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a femur $x chemie $7 D005269
650    _2
$a glukokortikoidy $x škodlivé účinky $x terapeutické užití $7 D005938
650    _2
$a lidé $7 D006801
650    _2
$a bérec $7 D007866
650    _2
$a bederní obratle $x chemie $7 D008159
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a svalová atrofie $x etiologie $x patologie $7 D009133
650    _2
$a velikost orgánu $7 D009929
650    _2
$a orgánová specificita $7 D009928
650    _2
$a tělesná výkonnost $7 D010809
650    _2
$a radius $x chemie $7 D011884
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jarosova, Katerina
700    1_
$a Pavelka, Karel
700    1_
$a Stepan, Jan J
773    0_
$w MED00008193 $t BMC musculoskeletal disorders $x 1471-2474 $g Roč. 15, č. - (2014), s. 51
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24558956 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150313101422 $b ABA008
999    __
$a ok $b bmc $g 1065555 $s 891082
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 15 $c - $d 51 $i 1471-2474 $m BMC musculoskeletal disorders $n BMC Musculoskelet Disord $x MED00008193
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...